216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/66/37/0f/66370f51-a728-31af-6862-ec4061c1eea2/mza_2612339221923582734.jpg/600x600bb.jpg

Let's Combinate - Drugs + Devices

Subhi Saadeh

226 episodes

5 days ago

Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to listen and together we can simplify by Combinating!

Life Sciences

Science

RSS

All content for Let's Combinate - Drugs + Devices is the property of Subhi Saadeh and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/17254408/17254408-1735275370987-64c671ec88d89.jpg

216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

Let's Combinate - Drugs + Devices

21 minutes 51 seconds

1 month ago

216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

In this episode of Let’s Combinate: Drugs + Devices, host Subhi Saadeh speaks with Steven O'Rourke, regulatory strategist and founder of Clarifi, a consultancy helping MedTech, biotech, and novel food startups navigate EU and US regulatory pathways.

They discuss:

- The hidden costs of regulatory failure and how to avoid them

- Why early engagement with regulatory agencies is critical

- Global regulatory models, including emerging markets like China and the UAE

- A clear explanation of UDI and serialization

- How regulatory impacts extend beyond compliance teams

- The role of LinkedIn and storytelling in regulatory careers

- Steven’s experience running for the European Parliament and what it taught him about policy

Timestamps

00:00 – Introduction and Guest Welcome

00:38 – The Hidden Costs of Regulatory Failure

03:47 – Engaging with Regulators Early

05:26 – Global Regulatory Models and Emerging Markets

10:07 – Understanding UDI and Serialization

15:16 – The Power of LinkedIn and Personal Stories

17:11 – Running for European Parliament and Policy Insights

21:18 – Conclusion and Contact Information

Connect with Steven O’Rourke

Website: https://clarifi.fi

LinkedIn: https://linkedin.com/in/sorourkde

Subscribe to Let’s Combinate for more conversations exploring combination product development, quality systems, and regulatory strategy.

Stephen O’Rourke is a regulatory strategist and founder of Clarifi, a consultancy helping MedTech, biotech, and novel food startups navigate EU and US regulatory pathways. Based in Helsinki, Finland, his work spans UDI, 510(k), EU MDR, combination products, and novel ingredient safety.

Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.